Duke Rohlen Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Duke Rohlen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Duke Rohlen. Duke Rohlen is a President Strategic Operations in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and a President, Molecular Programs in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and a Director in ENTELLUS MEDICAL INC ($ENTL) and a Director in Eidos Therapeutics, Inc. ($EIDX).
Address: C/O FOXHOLLOW TECHNOLOGIES, INC. 740 BAY ROAD REDWOOD CITY 94063 CA
Companies in which Duke Rohlen is an Insider
Eidos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Duke Rohlen: Director
Holdings: 0 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ENTELLUS MEDICAL INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Duke Rohlen: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 01 2018
$ENTL Market Capitalization: $316.35M
$ENTL Previous Close: $16.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FOXHOLLOW TECHNOLOGIES, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Duke Rohlen: President Strategic Operations, President, Molecular Programs
Holdings: 406,757 shares
Latest Transaction: Feb 22 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Duke Rohlen
Sentiment: All, EIDX, ENTL, FOXH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 0.00 | 4,526 | 0 | 0 | |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 41.42 | 21,447 | 888,335 | 0 | |
| Aug 10 2020 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | A | 41.42 | 21,447 | 888,335 | 21,447 | |
| Aug 10 2020 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | A | 0.00 | 4,526 | 0 | 4,526 | |
| Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Option Exercise | D | 17.67 | 7,500 | 132,525 | 0 | |
| Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Option Exercise | D | 17.67 | 7,500 | 132,525 | 0 | |
| Mar 01 2018 | ENTL | ENTELLUS MEDICAL I ... | Rohlen Douglas | Director | Sell | D | 24.00 | 4,684 | 112,416 | 0 | 4.7 K to 0 (-100.00 %) |